Chevron Left
Zurück zu Drug Commercialization

Bewertung und Feedback des Lernenden für Drug Commercialization von University of California San Diego

4.7
Sterne
1,040 Bewertungen
193 Bewertungen

Über den Kurs

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Commercialization course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug commercialization. This course will cover pharmacoeconomic, marketing strategy, intellectual property strategy, portfolio management, managed markets and strategic alliances. It will also have a lecture case study from startup to success. In addition, the course will discuss post-marketing clinical trials or Phase 4 trials. These are conducted after a new drug has been approved by the regulatory agencies and launched. In these studies, the new drug is prescribed in an everyday healthcare environ­ment using a much larger group of patients. This enables new treat­ment uses for the new drug to be developed, comparisons with other treatments for the same indication to be made, and determination of the clinical effectiveness of the new drug in a wider variety of patient types, and more rare side effects, if any, may be detected . Pre-marketing strategy should be instigated as early as Phase 1 clinical trials to ensure that the market's needs are incorporated into the new drug's overall develop­ment. Later phases when clinical results are presented at international medical conferences the marketing strategy is then refined in order to develop an awareness amongst the medical community who will be prescribing the new drug. In addition to the marketing strategy, pricing strategy and a tactical plan will be developed. Promotional material, and the sales force will be trained so that when the product is approved they can promote the drug to physician, pharmacist and nurses. This course is intended as part 3 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development (https://www.coursera.org/learn/drug-development) and Drug Commercialization. We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....

Top-Bewertungen

JR
7. Jan. 2017

Excellent course on strategies for drug commercialization including pharmacoeconomics and how pharma partners with other stakeholders to accomplish this. Excellent examples of drug lifecycles.

FX
12. Mai 2020

Great contents covering economics, marketing, regulation, IP, academics-industry collaboration, and actual successful biotech startup stories. I highly recommended this course.

Filtern nach:

126 - 150 von 194 Bewertungen für Drug Commercialization

von Dr. S T

17. Okt. 2020

nice experience

von ALISA C D

11. Aug. 2020

Love the course

von Prasun N

19. Juni 2020

great learning

von �ADITI P

24. Sep. 2020

...........

von Utku U

8. Apr. 2020

Excellent!

von Sourav M

3. Nov. 2018

Thank you.

von PANDYA Y U

28. Mai 2020

Excellant

von Afroj K

19. Mai 2020

Excellent

von Ngân Đ N T

30. Nov. 2020

Love it

von Lokesh

19. Okt. 2020

Amazing

von MRS. S

26. Aug. 2020

Helpful

von NABHAN M H A

26. Nov. 2021

thanks

von Mintu S T

30. Sep. 2020

Cool!!

von Atocha C S

29. Nov. 2017

Great!

von Md. R Q S

11. Sep. 2020

great

von Farhan s

24. Apr. 2021

good

von 19BBT006-ANASWAR S B B B

13. Sep. 2020

Good

von Uma M K

17. Juli 2020

Good

von Mohammad j s

25. Sep. 2017

good

von Julen D L C

12. Jan. 2020

The course is pretty good and really interesting, but it is too out-of-date. I think that this course would win a lot if actualized. Sometimes, the content should be more accurate, and in order to make it more useful for (future) workers on the pharmaceutical industry, I think this scheme should be followed in all subjects: present a topic --> main keys to follow when working on this area --> practical examples. Thank you!

von Aedrian A

16. Jan. 2021

This is a highly insightful course on the reality (both the highs and lows) of the drug commercialization process. Unfortunately, as of this writing, the material is relatively outdated. I hope the instructors provide a necessary massive updating of the contents as soon as possible.

von Olivia P L M

22. Mai 2020

Great course that allows me to look somewhat into health economics and other areas such as marketing. It also shows me statistics that can be quite alarming at times. Definitely learnt a lot of interesting terms and built on new knowledge due to this course. Thank you!

von David L

24. Mai 2020

Nice introduction to drug commercialization. It's a bit out of date though. The examples were current at the time, but new modalities, i.e. mAbs, cell and gene therapies, have rapidly overtaken small molecules as the "hottest" entities for commercialization.

von Abram S

25. Juni 2020

Holistic view of the commercial side of the industry from many different angles. Excellent and varied speakers with interesting cases. The only negative point is the lack of more current data (ending around 2015).

von Anindita R

20. Sep. 2020

Liked the course and learned some interesting information about the pharma and biotech industry. I would have appreciated more updated information, however, those can be found on the internet with some research.